Host Innate Immunity Against Hepatitis Viruses and Viral Immune Evasion.

Chonghui Xu, Jizheng Chen, Xinwen Chen
Author Information
  1. Chonghui Xu: State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  2. Jizheng Chen: State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  3. Xinwen Chen: State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.

Abstract

Hepatitis viruses are primary causative agents of hepatitis and represent a major source of public health problems in the world. The host innate immune system forms the first line of defense against hepatitis viruses. Hepatitis viruses are sensed by specific pathogen recognition receptors (PRRs) that subsequently trigger the innate immune response and interferon (IFN) production. However, hepatitis viruses evade host immune surveillance via multiple strategies, which help compromise the innate immune response and create a favorable environment for viral replication. Therefore, this article reviews published findings regarding host innate immune sensing and response against hepatitis viruses. Furthermore, we also focus on how hepatitis viruses abrogate the antiviral effects of the host innate immune system.

Keywords

References

  1. Annu Rev Immunol. 2011;29:163-83 [PMID: 21219184]
  2. J Gastroenterol Hepatol. 2013 May;28(5):766-76 [PMID: 23432473]
  3. BMC Biochem. 2012 May 16;13:7 [PMID: 22590978]
  4. Cell Microbiol. 2015 Sep;17(9):1295-303 [PMID: 26243406]
  5. J Hepatol. 2013 Jul;59(1):52-8 [PMID: 23542348]
  6. Sci Rep. 2018 Jun 5;8(1):8585 [PMID: 29872132]
  7. J Hepatol. 2011 Oct;55(4):762-9 [PMID: 21334391]
  8. J Hepatol. 2015 Apr;62(4):771-8 [PMID: 25463548]
  9. Clin Res Hepatol Gastroenterol. 2013 Nov;37(5):491-5 [PMID: 23433963]
  10. Immunol Res. 2016 Feb;64(1):115-22 [PMID: 26492885]
  11. J Virol. 2005 Jun;79(11):7269-72 [PMID: 15890966]
  12. Cytokine. 2008 Sep;43(3):336-41 [PMID: 18694646]
  13. Cold Spring Harb Perspect Med. 2019 Mar 1;9(3): [PMID: 29686040]
  14. PLoS Pathog. 2018 May 21;14(5):e1007075 [PMID: 29782532]
  15. PLoS One. 2014 Jun 24;9(6):e100787 [PMID: 24959724]
  16. J Hepatol. 2017 Oct;67(4):669-679 [PMID: 28527664]
  17. J Med Virol. 2021 Aug;93(8):4957-4965 [PMID: 33783003]
  18. Life Sci. 2016 Aug 1;158:63-9 [PMID: 27373425]
  19. Virology. 2004 Feb 20;319(2):306-14 [PMID: 14980490]
  20. J Clin Invest. 2015 Jan;125(1):169-76 [PMID: 25415438]
  21. Inflamm Res. 2012 Sep;61(9):997-1004 [PMID: 22684144]
  22. Front Immunol. 2020 Apr 28;11:615 [PMID: 32411126]
  23. Am J Physiol Gastrointest Liver Physiol. 2011 Apr;300(4):G516-25 [PMID: 21252049]
  24. Cell Mol Immunol. 2016 May;13(3):265-6 [PMID: 27041634]
  25. Hepatology. 2020 Apr;71(4):1154-1169 [PMID: 31402464]
  26. PLoS Pathog. 2017 May 30;13(5):e1006417 [PMID: 28558073]
  27. PLoS Pathog. 2011 Sep;7(9):e1002169 [PMID: 21931545]
  28. Optom Vis Sci. 1995 Oct;72(10):763-9 [PMID: 8570167]
  29. World J Gastroenterol. 2012 Jun 14;18(22):2850-8 [PMID: 22719196]
  30. Baillieres Clin Gastroenterol. 1990 Mar;4(1):201-32 [PMID: 2207351]
  31. Hepatology. 2012 Mar;55(3):666-75 [PMID: 22030901]
  32. Clin Immunol. 2008 Sep;128(3):400-8 [PMID: 18565796]
  33. J Virol. 2014 Sep;88(18):10412-20 [PMID: 24872585]
  34. Liver Int. 2016 Jan;36 Suppl 1:135-40 [PMID: 26725911]
  35. Hepatol Int. 2017 Jan;11(1):79-86 [PMID: 27193024]
  36. Gastroenterol Res Pract. 2015;2015:572171 [PMID: 25983748]
  37. Nat Rev Immunol. 2008 Aug;8(8):594-606 [PMID: 18641647]
  38. Science. 2003 May 16;300(5622):1145-8 [PMID: 12702807]
  39. Hepatology. 2009 Apr;49(4):1132-40 [PMID: 19140219]
  40. Arch Pathol Lab Med. 2013 Nov;137(11):1674-9 [PMID: 24168509]
  41. J Virol. 2014 Sep 1;88(17):10252-8 [PMID: 24920812]
  42. J Gen Virol. 2008 Jul;89(Pt 7):1593-1604 [PMID: 18559929]
  43. FEBS J. 2016 Jan;283(1):144-56 [PMID: 26471009]
  44. J Hepatol. 2019 Mar;70(3):501-520 [PMID: 30472320]
  45. PLoS One. 2017 Jan 5;12(1):e0169701 [PMID: 28056087]
  46. J Virol. 2015 Feb;89(4):2287-300 [PMID: 25505063]
  47. J Virol. 2006 Jan;80(2):866-74 [PMID: 16378988]
  48. J Hepatol. 2015 Aug;63(2):346-53 [PMID: 25795587]
  49. Lancet. 2011 Jul 2;378(9785):73-85 [PMID: 21511329]
  50. Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2992-7 [PMID: 15710891]
  51. Biochem Biophys Res Commun. 2007 Sep 21;361(2):537-42 [PMID: 17662694]
  52. Trends Immunol. 2019 Dec;40(12):1134-1148 [PMID: 31735513]
  53. PLoS Pathog. 2013;9(8):e1003533 [PMID: 23950712]
  54. J Virol. 2002 Dec;76(23):11920-30 [PMID: 12414934]
  55. J Biol Chem. 2020 Sep 11;295(37):13123-13133 [PMID: 32719095]
  56. Nat Immunol. 2018 Mar;19(3):222-232 [PMID: 29379119]
  57. Hepatology. 2008 Feb;47(2):729-36 [PMID: 18167066]
  58. Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2986-91 [PMID: 15710892]
  59. J Viral Hepat. 2011 Oct;18(10):e499-507 [PMID: 21914069]
  60. World J Gastroenterol. 2016 Dec 21;22(47):10341-10352 [PMID: 28058014]
  61. Hepatology. 2005 May;41(5):1004-12 [PMID: 15841462]
  62. PLoS One. 2011;6(10):e26315 [PMID: 22046272]
  63. Biochem Pharmacol. 2021 Jan;183:114316 [PMID: 33152343]
  64. J Gen Virol. 2010 Aug;91(Pt 8):2080-2090 [PMID: 20375222]
  65. Hepatology. 2012 May;55(5):1324-32 [PMID: 22183878]
  66. J Virol. 2013 Nov;87(21):11416-25 [PMID: 23966395]
  67. Gastroenterology. 2004 Nov;127(5):1513-24 [PMID: 15521019]
  68. Biomed Res Int. 2014;2014:491064 [PMID: 25126563]
  69. Nature. 2008 Jul 24;454(7203):523-7 [PMID: 18548002]
  70. Hepatology. 2014 Oct;60(4):1170-9 [PMID: 24833036]
  71. Mol Immunol. 2009 Aug;46(13):2640-6 [PMID: 19501403]
  72. Hepatology. 2016 Sep;64(3):746-59 [PMID: 27312012]
  73. Adv Exp Med Biol. 2020;1179:1-16 [PMID: 31741331]
  74. iScience. 2021 Jan 04;24(1):101969 [PMID: 33458618]
  75. J Hepatol. 2017 May;66(5):897-909 [PMID: 28043874]
  76. Proc Natl Acad Sci U S A. 2007 Apr 24;104(17):7253-8 [PMID: 17438296]
  77. Hepatology. 2021 Feb;73(2):533-547 [PMID: 32394474]
  78. J Hepatol. 2009 Jul;51(1):29-38 [PMID: 19443072]
  79. J Clin Virol. 2015 Dec;73:8-13 [PMID: 26512422]
  80. Biochem Biophys Res Commun. 2009 Dec 18;390(3):630-5 [PMID: 19833099]
  81. Cell Mol Immunol. 2010 Sep;7(5):341-8 [PMID: 20711230]
  82. Cold Spring Harb Perspect Med. 2018 Dec 3;8(12): [PMID: 29610146]
  83. J Hepatol. 2018 Jul;69(1):25-35 [PMID: 29524530]
  84. J Gen Virol. 2016 Dec;97(12):3368-3378 [PMID: 27902332]
  85. J Immunol. 2013 Sep 15;191(6):3264-76 [PMID: 23926323]
  86. J Med Virol. 2017 Dec;89(12):2165-2172 [PMID: 28480979]
  87. Hum Pathol. 2013 Apr;44(4):534-41 [PMID: 23069256]
  88. J Huazhong Univ Sci Technolog Med Sci. 2009 Jun;29(3):313-7 [PMID: 19513613]
  89. J Microbiol. 2019 Dec;57(12):1126-1131 [PMID: 31758397]
  90. Arch Iran Med. 2015 Jun;18(6):351-4 [PMID: 26058929]
  91. Arch Virol. 2021 Mar;166(3):789-799 [PMID: 33459883]
  92. J Virol. 2019 Jan 4;93(2): [PMID: 30404796]
  93. J Gen Virol. 2007 Dec;88(Pt 12):3260-3269 [PMID: 18024894]
  94. Mikrobiyol Bul. 2020 Jan;54(1):66-78 [PMID: 32050879]
  95. Hepatology. 2020 Sep;72(3):829-844 [PMID: 31925967]
  96. Postgrad Med J. 2014 Jul;90(1065):396-401 [PMID: 24942353]
  97. Cold Spring Harb Perspect Med. 2018 Sep 4;8(9): [PMID: 29530950]
  98. Oncol Rep. 2018 Aug;40(2):1035-1045 [PMID: 29916535]
  99. Gut. 2017 Oct;66(10):1829-1837 [PMID: 27196570]
  100. J Virol. 2014 Aug;88(15):8696-705 [PMID: 24850742]
  101. Hepatology. 2009 Feb;49(2):398-406 [PMID: 19085955]
  102. Adv Exp Med Biol. 2016;948:1-16 [PMID: 27738976]
  103. J Mol Biol. 2014 Mar 20;426(6):1246-64 [PMID: 24316048]
  104. PLoS Pathog. 2015 Apr 22;11(4):e1004840 [PMID: 25902143]
  105. Biochem Biophys Res Commun. 2015 Aug 7;463(4):719-25 [PMID: 26047698]
  106. J Hepatol. 2017 Apr;66(4):693-702 [PMID: 28027970]
  107. Nat Commun. 2021 Jan 4;12(1):98 [PMID: 33397935]
  108. J Virol. 2019 Nov 13;93(23): [PMID: 31534039]
  109. Proc Natl Acad Sci U S A. 2005 Dec 6;102(49):17717-22 [PMID: 16301520]
  110. Hepatology. 2017 Jun;65(6):1823-1839 [PMID: 28195391]
  111. Immunity. 2015 Jan 20;42(1):123-32 [PMID: 25557055]
  112. J Immunol. 2010 Jul 15;185(2):1158-68 [PMID: 20554965]
  113. J Biol Chem. 2007 Apr 6;282(14):10792-803 [PMID: 17289677]
  114. J Clin Lab Anal. 2019 Jun;33(5):e22886 [PMID: 30924966]
  115. PLoS Pathog. 2013;9(4):e1003330 [PMID: 23633957]
  116. Epidemiol Infect. 2019 Jan;147:e195 [PMID: 31364528]
  117. Zhonghua Gan Zang Bing Za Zhi. 2007 Oct;15(10):729-33 [PMID: 17963596]
  118. Gastroenterology. 1993 Apr;104(4):955-63 [PMID: 8385046]
  119. J Virol. 2011 Jan;85(2):987-95 [PMID: 21068253]
  120. Science. 2016 Sep 30;353(6307):1541-1545 [PMID: 27633528]
  121. Antiviral Res. 2016 Dec;136:19-31 [PMID: 27771387]
  122. J Microbiol Biotechnol. 2018 Sep 28;28(9):1554-1562 [PMID: 30199924]
  123. Front Microbiol. 2020 Apr 15;11:656 [PMID: 32351484]
  124. Hepatology. 2013 Jan;57(1):46-58 [PMID: 22911572]
  125. Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7431-6 [PMID: 20231459]
  126. J Microbiol Biotechnol. 2019 Jul 28;29(7):1137-1143 [PMID: 31216792]
  127. J Virol. 2005 Sep;79(17):10968-77 [PMID: 16103148]
  128. Proc Natl Acad Sci U S A. 2011 Jul 5;108(27):11223-8 [PMID: 21690403]
  129. Antiviral Res. 2020 Apr;176:104743 [PMID: 32057771]
  130. mBio. 2020 Jan 14;11(1): [PMID: 31937650]
  131. Viruses. 2020 May 29;12(6): [PMID: 32485908]
  132. Hepatology. 2019 Jan;69(1):34-50 [PMID: 30070380]
  133. Biol Chem. 2017 Jul 26;398(8):817-837 [PMID: 28455951]
  134. Sci Rep. 2016 Jun 08;6:27597 [PMID: 27270888]
  135. J Virol. 2014 Oct;88(20):11924-32 [PMID: 25100852]
  136. Nature. 2005 Oct 20;437(7062):1167-72 [PMID: 16177806]
  137. Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):6001-6 [PMID: 16585524]
  138. Cold Spring Harb Perspect Med. 2018 Sep 4;8(9): [PMID: 29440324]
  139. J Virol. 2008 Jan;82(2):609-16 [PMID: 17977974]
  140. Viral Immunol. 2015 Nov;28(9):504-8 [PMID: 26485346]
  141. J Hepatol. 2015 Oct;63(4):829-37 [PMID: 25908268]

Word Cloud

Created with Highcharts 10.0.0immuneviruseshepatitisinnatehostHepatitisresponsesystemviralreplicationantiviralprimarycausativeagentsrepresentmajorsourcepublichealthproblemsworldformsfirstlinedefensesensedspecificpathogenrecognitionreceptorsPRRssubsequentlytriggerinterferonIFNproductionHoweverevadesurveillanceviamultiplestrategieshelpcompromisecreatefavorableenvironmentThereforearticlereviewspublishedfindingsregardingsensingFurthermorealsofocusabrogateeffectsHostInnateImmunityVirusesViralImmuneEvasionimmunityvirusevasioninfection

Similar Articles

Cited By